Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal cone cell | 7 studies | 52% ± 13% | |
retinal rod cell | 6 studies | 41% ± 16% | |
GABAergic neuron | 3 studies | 28% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
eye | 5 studies | 29% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 274.60 | 2544 / 2642 | 80% | 3.25 | 563 / 705 |
kidney | 82% | 103.54 | 73 / 89 | 17% | 0.39 | 152 / 901 |
pancreas | 79% | 89.63 | 258 / 328 | 8% | 0.71 | 15 / 178 |
liver | 50% | 57.27 | 114 / 226 | 35% | 1.66 | 143 / 406 |
muscle | 85% | 261.53 | 685 / 803 | 0% | 0 | 0 / 0 |
skin | 71% | 528.70 | 1284 / 1809 | 11% | 0.29 | 54 / 472 |
breast | 62% | 94.92 | 284 / 459 | 15% | 0.36 | 172 / 1118 |
ovary | 1% | 0.73 | 2 / 180 | 69% | 2.54 | 295 / 430 |
intestine | 54% | 54.33 | 524 / 966 | 9% | 0.26 | 48 / 527 |
heart | 49% | 54.91 | 424 / 861 | 0% | 0 | 0 / 0 |
adipose | 40% | 56.69 | 486 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 7% | 7.91 | 19 / 258 | 32% | 1.04 | 73 / 230 |
prostate | 27% | 37.54 | 66 / 245 | 11% | 0.20 | 55 / 502 |
lymph node | 0% | 0 | 0 / 0 | 31% | 1.08 | 9 / 29 |
stomach | 21% | 18.56 | 74 / 359 | 9% | 0.22 | 26 / 286 |
esophagus | 17% | 13.17 | 244 / 1445 | 11% | 0.26 | 20 / 183 |
thymus | 20% | 14.90 | 132 / 653 | 2% | 0.05 | 15 / 605 |
lung | 9% | 6.86 | 54 / 578 | 5% | 0.13 | 57 / 1155 |
uterus | 2% | 1.63 | 4 / 170 | 10% | 0.88 | 47 / 459 |
eye | 0% | 0 | 0 / 0 | 8% | 0.92 | 6 / 80 |
bladder | 0% | 0 | 0 / 21 | 7% | 0.30 | 37 / 504 |
spleen | 3% | 1.78 | 7 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.16 | 1 / 45 |
blood vessel | 1% | 1.06 | 15 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 0.51 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090150 | Biological process | establishment of protein localization to membrane |
GO_0008277 | Biological process | regulation of G protein-coupled receptor signaling pathway |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005938 | Cellular component | cell cortex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | FRMPD1 |
Protein name | FERM and PDZ domain containing 1 FERM and PDZ domain-containing protein 1 (FERM domain-containing protein 2) |
Synonyms | FRMD2 KIAA0967 |
Description | FUNCTION: Stabilizes membrane-bound GPSM1, and thereby promotes its interaction with GNAI1. . |
Accessions | ENST00000539465.5 [Q5SYB0-1] ENST00000377765.8 [Q5SYB0-1] Q5SYB0 ENST00000359927.3 F5H0G3 |